Fibulin-3 also drives glioma invasiveness [110], a process mechanistically underpinned by modulation of the ECM surrounding the tumour through increasing expression of MMP2, MMP9, and ADAMTS-5 [92]. The gene discussed is MMP2; the disease is central nervous system cancer.